Cutler Group LP Syros Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 05, 2019	BUY	$5.55 - $11.34 $21,645 - $44,226	3,900 Added 325.0%	5,100 $1,000
Q2 2018 Aug 10, 2018	SELL	$10.16 - $13.65 $19,304 - $25,935	-1,900 Reduced 61.29%	1,200 $0
Q1 2018 May 11, 2018	BUY	$9.47 - $12.98 $15,152 - $20,768	1,600 Added 106.67%	3,100 $6,000
Q4 2017 Jan 17, 2018	BUY	$8.45 - $17.48 $12,674 - $26,220	1,500	1,500 $3,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.